Ageless Fund®
Ageless Fund® focuses on companies advancing AI, healthcare, and biotechnology to extend human healthspan. Reversing the aging process is one of the most important challenges of our time. This strategic initiative reflects ongoing research, engagement, and prior investment activity. Ageless Fund® provides early-stage venture support, research partnerships, and strategic insights to help innovators accelerate progress in longevity and regenerative medicine.
Investments
Biotechnology
Auctus Biologics is a pre-clinical biotechnology company developing antibody mimetics for therapeutic and diagnostic applications.
Artificial Intelligence
Anthropic is an AI safety and research company that’s working to build reliable, interpretable, and steerable AI systems.
The leading AI platform for finance, used by the world’s leading asset managers, investment banks, law firms and Fortune 500 companies
Maket AI is a specialized, generative AI platform designed for the AEC (Architecture, Engineering, and Construction) and real estate industries to automate residential design and planning.
Healthcare
Revero is a data-driven digital clinic with the mission to reverse autoimmune and other chronic diseases by addressing the root causes.
Companies shown represent past investments and are listed for informational purposes only. This page does not constitute an offer to sell or a solicitation of an offer to buy any securities.